BACKGROUND The aim of the present study was to investigate the protective effects of
protease inhibitor MG-132 on
sepsis-induced
acute lung injury rats. MATERIAL AND METHODS Sprague Dawley rats were employed to induce
sepsis by cecal
ligation and
puncture (CLP) method. Rats were divided into 4 groups: control,
sham, model (CLP), and
MG-132. Histopathology observation was detected by
hematoxylin and
eosin staining. The ratio of
wet lung to dry lung (W/D) was calculated. In addition, the levels of inflammatory factors in bronchoalveolar lavage fluid (BALF) were measured by
enzyme-linked
immunosorbent assay (ELISA). Also,
superoxide dismutase (SOD) and
malondialdehyde (MDA) levels were evaluated. Western blotting was performed to measure the expression of
hypoxia-inducible factor-1 alpha (HIF-1alpha). In order to assess the role of HIF-1alpha, YC-1, the inhibitor of HIF-1alpha, was used to treat the rats. The expression of phosphor-mTOR (p-mTOR), p-4EBP1, and p-EIF4E were evaluated by western blotting. RESULTS Obvious pathological injury and increasing ratio of W/D in the model group were observed. Both pathological injury and W/D were improved in the
MG-132 group, and the greatest improvement could be seen in the YC-1+MG-132 group. Furthermore, the MDA levels in the
MG-132 group was decreased, accompanied by an increase in SOD levels. The level of HIF-1alpha was increased in the model group while a decreased was detected in the
MG-132 group. The levels of inflammatory factors were high in the model group, whereas the opposite result was found in the
MG-132 group, and the lowest in were in the YC-1+MG-132 group. Furthermore, the expression levels of p-mTOR, p-4EBP1, and p-EIF4E
proteins were downregulated in the
MG-132 group compared to the model group, and the lowest was in the YC-1+MG-132 group. CONCLUSIONS Our study suggested that
MG-132 was able to protect against
acute lung injury via inhibition of HIF-1alpha mediated mTOR/4EBP1/
EIF4E pathway.